BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7983601)

  • 1. General treatment of competitive binding as applied to the potentiometric ion probe technique: application to the interaction of nonsteroidal anti-inflammatory drugs with bovine serum albumin.
    Angelakou AT; Sideris EE; Valsami GN; Koupparis MA; Macheras PE
    J Pharm Sci; 1994 Aug; 83(8):1150-4. PubMed ID: 7983601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A displacement approach for competitive drug-protein binding studies using the potentiometric 1-anilino-8-naphthalene-sulfonate probe technique.
    Angelakou A; Valsami G; Macheras P; Koupparis M
    Eur J Pharm Sci; 1999 Dec; 9(2):123-30. PubMed ID: 10620724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated flow injection gradient technique for binding studies of micromolecules to proteins using potentiometric sensors: application to bovine serum albumin with anilinonaphthalenesulfonate probe and drugs.
    Georgiou ME; Georgiou CA; Koupparis MA
    Anal Chem; 1999 Jul; 71(13):2541-50. PubMed ID: 10405613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding study of the fluorescence probe 1-anilino-8-naphthalensulfonate to human plasma and human and bovine serum albumin using potentiometric titration.
    Valsami GN; Macheras PE; Koupparis MA
    Pharm Res; 1991 Jul; 8(7):888-92. PubMed ID: 1924140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of 1-anilino-8-napthalenesulphonate as an ion probe for the potentiometric study of the binding of sulphonamides to bovine serum albumin and plasma.
    Angelakou A; Valsami G; Koupparis M; Macheras P
    J Pharm Pharmacol; 1993 May; 45(5):434-8. PubMed ID: 8099962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin.
    Diana FJ; Veronich K; Kapoor AL
    J Pharm Sci; 1989 Mar; 78(3):195-9. PubMed ID: 2724076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of branched-chain 2-oxo acids to bovine serum albumin.
    Livesey G; Lund P
    Biochem J; 1982 Apr; 204(1):265-72. PubMed ID: 7115325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive binding of ibuprofen and naproxen to bovine serum albumin : modified form of drug-drug displacement interaction at the binding site.
    Rahman MM; Rahman MH; Rahman NN
    Pak J Pharm Sci; 2005 Jan; 18(1):43-7. PubMed ID: 16431382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for Carboxylic Acid Moiety in NSAIDs: Favoring the Binding at Site II of Bovine Serum Albumin.
    de Carvalho Bertozo L; Tadeu HC; Sebastian A; Maszota-Zieleniak M; Samsonov SA; Ximenes VF
    Mol Pharm; 2024 May; 21(5):2501-2511. PubMed ID: 38574292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative Cooperativity in the Interaction of Prostaglandin H Synthase-1 with the Competitive Inhibitor Naproxen Can Be Described as the Interaction of a Non-competitive Inhibitor with Heterogeneous Enzyme Preparation.
    Filimonov IS; Berzova AP; Barkhatov VI; Krivoshey AV; Trushkin NA; Vrzheshch PV
    Biochemistry (Mosc); 2018 Feb; 83(2):119-128. PubMed ID: 29618298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroxine-protein interactions. Interaction of thyroxine and triiodothyronine with human thyroxine-binding globulin.
    Korcek L; Tabachnick M
    J Biol Chem; 1976 Jun; 251(12):3558-62. PubMed ID: 6458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-9-tetrahydrocannabinol and theophylline: in vitro interaction with bovine serum albumin.
    Ghosh SK; Poddar MK
    Indian J Biochem Biophys; 1993 Feb; 30(1):21-5. PubMed ID: 8389726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of copper(II) with the non-steroidal anti-inflammatory drugs naproxen and diclofenac: synthesis, structure, DNA- and albumin-binding.
    Dimiza F; Perdih F; Tangoulis V; Turel I; Kessissoglou DP; Psomas G
    J Inorg Biochem; 2011 Mar; 105(3):476-89. PubMed ID: 20926136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
    Albengres E; Urien S; Kusmierek J; Tillement JP
    Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of interaction of carprofen and its enantiomers with human serum albumin--I. Mechanism of binding studied by dialysis and spectroscopic methods.
    Rahman MH; Maruyama T; Okada T; Yamasaki K; Otagiri M
    Biochem Pharmacol; 1993 Nov; 46(10):1721-31. PubMed ID: 7504487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of interaction of the non-steroidal antiinflammatory drugs meloxicam and nimesulide with serum albumin.
    Seedher N; Bhatia S
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):257-62. PubMed ID: 16085140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of competitive binding of ibuprofen and salicylic acid with serum albumin by affinity capillary electrophoresis.
    Li ZM; Wei CW; Zhang Y; Wang DS; Liu YN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1934-8. PubMed ID: 21676661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using difference spectrophotometry to study the influence of different ions and buffer systems on drug protein binding.
    Afifi NN
    Drug Dev Ind Pharm; 1999 Jun; 25(6):735-43. PubMed ID: 10349559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.